Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2023-08-01 Director's Dealing
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and specific transaction changes (장내매수 - open market purchase) by an executive (조준성) of the company '주식회사 툴젠'. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which maps directly to the 'Director's Dealing' category.
2023-08-01 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by ToolGen. It details the patent name, technical content, and application plans. Since it is a regulatory announcement of a specific corporate event (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2023-07-28 Korean
투자판단관련주요경영사항(CRISPR 유전자 교정기술 특허 라이선스부여계약 체결)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the company ToolGen regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically detailing a CRISPR gene editing technology patent licensing agreement. This type of disclosure regarding business contracts, licensing, and strategic partnerships falls under general regulatory announcements as it does not fit into specific categories like M&A (which usually implies corporate control changes) or financial reports. Therefore, it is classified as a Regulatory Filing (RNS).
2023-07-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Lee Byong Hwa) of the company ToolGen. This type of filing is a standard regulatory requirement for reporting insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2023-07-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details changes in share ownership by a major shareholder (Genexine) and its special related parties (directors/executives) in the issuer (ToolGen). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2023-07-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Lee Byong Hwa) of ToolGen. This type of filing is a standard regulatory requirement for reporting insider transactions (director's dealings) in South Korea. It details the specific change in share ownership (장내매수 - open market purchase) by an executive, which aligns perfectly with the 'Director's Dealing' category.
2023-07-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.